Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Jun-24 7:58 PM View:  | Jones Kristi President and CEO Director | Neximmune, Inc. (NEXI) | 11-Jun-24 | Private Purchase | 1 | $0.01 | $0.01 | 100% 0 to 1 | |
| 22-Nov-23 5:18 PM View: | Roemer Alan S. Director | Neximmune, Inc. (NEXI) | 22-Nov-23 | Sale | 3,992 | $1.94 | $7,758.05 | (100%) 3.99K to 0 | |
| 22-Nov-23 5:18 PM View: | Roemer Alan S. Director | Neximmune, Inc. (NEXI) | 21-Nov-23 | Sale | 3,833 | $2.16 | $8,287.33 | (49%) 7.83K to 3.99K | |
| 31-Mar-23 4:56 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 30-Mar-23 | Private Purchase | 400,000 | $0.41 | $164,120.00 | 11% 3.7M to 4.1M | |
| 29-Nov-22 5:09 PM View: | Jones Kristi President and CEO Director | Neximmune, Inc. (NEXI) | 26-Nov-22 | Grant | 296,700 | -- | -- | 406% 73.08K to 369.78K | |
| 25-Nov-22 5:05 PM View: | Trainer John Chief Financial Officer | Neximmune, Inc. (NEXI) | 22-Nov-22 | Grant | 125,200 | -- | -- | 203% 61.77K to 186.97K | |
| 25-Nov-22 5:04 PM View: | Oelke Mathias Chief Science Officer | Neximmune, Inc. (NEXI) | 22-Nov-22 | Grant | 126,100 | -- | -- | 1592% 7.92K to 134.02K | |
| 17-Nov-22 8:40 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 17-Nov-22 | Purchase | 75,000 | $0.48 | $35,917.50 | 2% 3.63M to 3.7M | |
| 17-Nov-22 8:40 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 16-Nov-22 | Private Purchase | 125,000 | $0.48 | $60,300.00 | 4% 3.5M to 3.63M | |
| 07-Jun-22 6:17 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 07-Jun-22 | Purchase | 26,876 | $2.28 | $61,384.80 | 2% 1.08M to 1.11M | |
| 07-Jun-22 6:17 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 06-Jun-22 | Purchase | 25,000 | $2.14 | $53,537.50 | 2% 1.05M to 1.08M | |
| 07-Jun-22 6:17 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 03-Jun-22 | Private Purchase | 15,000 | $2.22 | $33,373.50 | 1% 1.04M to 1.05M | |
| 02-Jun-22 7:42 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 02-Jun-22 | Purchase | 47,900 | $2.23 | $106,683.00 | 5% 990.72K to 1.04M | |
| 02-Jun-22 7:41 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 02-Jun-22 | Purchase | 20,720 | $2.22 | $46,099.90 | < 1% 3.48M to 3.5M | |
| 02-Jun-22 7:41 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 01-Jun-22 | Purchase | 40,000 | $2.35 | $94,160.00 | 1% 3.44M to 3.48M | |
| 02-Jun-22 7:42 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 01-Jun-22 | Purchase | 40,200 | $2.38 | $95,760.40 | 4% 950.52K to 990.72K | |
| 02-Jun-22 7:41 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 31-May-22 | Private Purchase | 39,280 | $2.19 | $85,893.60 | 1% 3.4M to 3.44M | |
| 02-Jun-22 7:42 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 31-May-22 | Private Purchase | 45,024 | $2.11 | $95,117.70 | 5% 905.5K to 950.52K | |
| 30-Mar-22 7:57 PM View: | Jones Kristi President and CEO Director | Neximmune, Inc. (NEXI) | 29-Mar-22 | Private Purchase | 10,000 | $3.74 | $37,400.00 | 16% 63.08K to 73.08K | |
| 28-Mar-22 4:15 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 28-Mar-22 | Purchase | 18,983 | $3.76 | $71,376.10 | 2% 886.51K to 905.5K | |
| 28-Mar-22 4:15 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 25-Mar-22 | Purchase | 131,622 | $4.14 | $544,915.00 | 17% 754.89K to 886.51K | |
| 28-Mar-22 4:15 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 24-Mar-22 | Private Purchase | 39,995 | $3.35 | $133,983.00 | 6% 714.89K to 754.89K | |
| 24-Mar-22 4:15 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 23-Mar-22 | Private Purchase | 10,000 | $2.67 | $26,653.00 | < 1% 3.39M to 3.4M | |
| 23-Mar-22 4:15 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 22-Mar-22 | Private Purchase | 30,000 | $2.41 | $72,300.00 | < 1% 3.36M to 3.39M | |
| 22-Mar-22 4:15 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 21-Mar-22 | Private Purchase | 30,000 | $2.14 | $64,080.00 | < 1% 3.33M to 3.36M | |
| 21-Mar-22 4:10 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 18-Mar-22 | Private Purchase | 30,000 | $2.11 | $63,210.00 | < 1% 3.3M to 3.33M | |
| 22-Dec-21 8:00 AM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 21-Dec-21 | Option Exercise | 50,000 | $5.17 | $258,500.00 | 2% 3.25M to 3.3M | |
| 22-Dec-21 5:00 PM View: | Roemer Alan S. Director | Neximmune, Inc. (NEXI) | 21-Dec-21 | Option Exercise | 67,657 | $3.63 | $245,867.00 | 53% 127.98K to 195.64K | |
| 09-Jul-21 4:19 PM View: | Trainer John Chief Financial Officer | Neximmune, Inc. (NEXI) | 08-Jul-21 | Option Exercise | 3,432 | $5.17 | $17,743.40 | 6% 58.34K to 61.77K | |
| 09-Jun-21 4:06 PM View: | Trainer John Chief Financial Officer | Neximmune, Inc. (NEXI) | 08-Jun-21 | Option Exercise | 3,432 | $5.17 | $17,743.40 | 6% 54.91K to 58.34K | |
| 19-May-21 4:16 PM View: | Trainer John Chief Financial Officer | Neximmune, Inc. (NEXI) | 08-May-21 | Option Exercise | 3,432 | $5.17 | $17,743.40 | 7% 51.47K to 54.91K | |
| 19-May-21 4:16 PM View: | Trainer John Chief Financial Officer | Neximmune, Inc. (NEXI) | 08-Apr-21 | Option Exercise | 3,432 | $5.17 | $17,743.40 | 7% 48.04K to 51.47K | |
| 12-Mar-21 2:00 PM View: | Trainer John Chief Financial Officer | Neximmune, Inc. (NEXI) | 10-Mar-21 | Option Exercise | 3,432 | $5.17 | $17,743.40 | 8% 44.61K to 48.04K | |
| 19-Feb-21 4:23 PM View: | d'Angio Paul Director | Neximmune, Inc. (NEXI) | 17-Feb-21 | Conversion | 27,847 | -- | -- | 100% 0 to 27.85K | |
| 19-Feb-21 4:26 PM View: | Roemer Alan S. Director | Neximmune, Inc. (NEXI) | 17-Feb-21 | Conversion | 127,984 | -- | -- | 100% 0 to 127.98K | |
| 19-Feb-21 4:25 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 17-Feb-21 | Purchase | 175,000 | $17.00 | $2,975,000.00 | 32% 539.89K to 714.89K | |
| 19-Feb-21 4:22 PM View: | Bertram Timothy Director | Neximmune, Inc. (NEXI) | 17-Feb-21 | Conversion | 71,749 | -- | -- | 1112% 6.45K to 78.2K | |
| 19-Feb-21 4:30 PM View: | Jones Kristi Chief Operating Officer | Neximmune, Inc. (NEXI) | 17-Feb-21 | Conversion | 14,738 | -- | -- | 31% 47.43K to 62.17K | |
| 19-Feb-21 4:30 PM View: | Zeldis Jerome B Executive VP of Research & Dev | Neximmune, Inc. (NEXI) | 17-Feb-21 | Purchase | 5,882 | $17.00 | $99,994.00 | 100% 0 to 5.88K | |
| 19-Feb-21 4:20 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 17-Feb-21 | Conversion | 800,182 | -- | -- | 115% 696.64K to 1.5M | |
| 19-Feb-21 4:20 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 17-Feb-21 | Purchase | 60,000 | $17.00 | $1,020,000.00 | 2% 3.19M to 3.25M | |
| 19-Feb-21 4:22 PM View: | Carmer Scott President and CEO Director | Neximmune, Inc. (NEXI) | 17-Feb-21 | Conversion | 7,058 | -- | -- | 100% 0 to 7.06K | |
| 19-Feb-21 4:30 PM View: | Jones Kristi Chief Operating Officer | Neximmune, Inc. (NEXI) | 17-Feb-21 | Purchase | 911 | $17.00 | $15,487.00 | 1% 62.17K to 63.08K | |
| 19-Feb-21 4:25 PM View: | Verstandig Grant Director | Neximmune, Inc. (NEXI) | 17-Feb-21 | Conversion | 539,895 | -- | -- | 100% 0 to 539.89K | |
| 19-Feb-21 4:20 PM View: | Barer Sol J Director | Neximmune, Inc. (NEXI) | 17-Feb-21 | Conversion | 1,695,580 | -- | -- | 113% 1.5M to 3.19M |
